AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Enrollment completed for phase II pilot study of vaccine for metastatic disease.(Brief Article)
2002 NOV 13 - (NewsRx.com & NewsRx.net) -- Biomira, Inc., (BIOM) (TSX: BRA) announced that the company has completed enrolment of its phase II pilot study of Theratope vaccine for metastatic colorectal cancer.
The 20-patient study was initiated in February 2002. Data from this trial are expected to be analyzed and available in mid-2003.
The Theratope vaccine phase II trial, conducted at the Cross Cancer Institute in Edmonton, Alberta, Canada, by lead investigator Dr. Charles Butts, from the Alberta Cancer Board, was designed to evaluate the safety of the vaccine in patients with metastatic colorectal cancer, as well as evaluating the ability of the vaccine to induce an immune response in these patients when given in combination with first line chemotherapy.
"Completing the enrollment of this trial is an important milestone for our phase II Theratope vaccine study in this indication," said Alex McPherson, MD, PhD, Biomira. "This is the first opportunity to accumulate data using Theratope vaccine in combination with chemotherapy. Data from this trial ...
- Phase II colorectal trial results for Theratope vaccine to be presented at...
- Newspaper article from: Vaccine Weekly April 16, 2003 700+ words
...that data from the company's phase II Theratope vaccine trial in metastatic colorectal cancer will be presented as a poster presentation...vaccine in patients with metastatic colorectal cancer, as well as to evaluate the ability...
- Phase II colorectal trial results for theratope vaccine to be presented at ASCO.
- Newspaper article from: Gastroenterology Week April 14, 2003 700+ words
...that data from the company's phase II Theratope vaccine trial in metastatic colorectal cancer will be presented as a poster presentation...vaccine in patients with metastatic colorectal cancer, as well as to evaluate the ability...
- THERATOPE Vaccine to Enter Phase III Clinical Trials.
- Press release article from: Business Wire August 20, 1997 700+ words
...breast cancer who were treated with THERATOPE vaccine. The proposed double blind, prospectively...provide the evidence as to whether THERATOPE vaccine can delay disease progression and...patients randomized to treatment with THERATOPE vaccine and patients randomized to a placebo...
- Metastatic breast cancer vaccine trial to continue.(Theratope vaccine)
- Magazine article from: Women's Health Weekly November 28, 2002 700+ words
...their phase III clinical trial of Theratope vaccine through its planned conclusion in...women with metastatic breast cancer. Theratope vaccine has fast-track designation with...collaborating on the development of Theratope vaccine, reached this decision after the...
- Data from Theratope Vaccine trial presented.
- Newspaper article from: Vaccine Weekly January 7, 2004 700+ words
...from the final analysis of their Theratope Vaccine phase III clinical trial in women...and survival in patients receiving Theratope vaccine and those on the KLH control arm...titres and to evaluate the impact of Theratope vaccine therapy on patients' health-related...
- Biomira Analyst Conference Call Notification Theratope Vaccine Phase III...
- Press release article from: PR Newswire December 5, 2003 700+ words
Biomira Inc. (TSX:BRA) and Merck KGaA of Darmstadt, Germany have scheduled a conference call, with public Web cast access for Monday, December 8, 2003 at 9:00 a.m. ET, to expand upon the previously released data on the Theratope(R) vaccine Phase III clinical trial as presented at a scientific
- Merck KGaA to announce European colorectal cancer study data of Erbitux...
- Press release article from: PR Newswire May 27, 2003 700+ words
...with metastatic colorectal cancer will be presented...cancer and metastatic colorectal cancer, each of which...abstracts about Theratope vaccine for the treatment...cancer and metastatic colorectal cancer have also been accepted...
- Merck KGaA to Announce European Colorectal Cancer Study Data of Erbitux...
- Press release article from: PR Newswire May 27, 2003 700+ words
...with metastatic colorectal cancer will be presented...cancer and metastatic colorectal cancer, each of which...abstracts about Theratope vaccine for the treatment...cancer and metastatic colorectal cancer have also been accepted...
Source: HighBeam Research, Enrollment completed for phase II pilot study of vaccine for...